Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: RX BANDZ, INC.
Awarding agency: Department of Defense / Department of the Air Force
Funding agency: Department of Defense / Department of the Air Force
Period of performance: 2023-09-18 to 2025-09-18
Current total value of award: $1799613.4
Description: TACTICAL FUNDING INCREASE (TACFI) FOR SBIR II CONTRACT FA864921P1557 TO DEVELOP PROTOTYPE DEVICES TO CONVERT THE SUBOPTIMAL MEDICATION ADMINISTRATION (SYRINGE AND MULTI-DOSE VIAL) TO AN AUTO-INJECTOR, ENABLING THE PAIN MEDICATION TO BE AVAILABLE FOR